Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Brindley

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Dose-proportional pharmacokinetics of cefepime in ratsC J Brindley, R R Brodie, S C Cook, et al.
Cancer Treatment Reports|July 1, 1985
Phase I clinical trial of mitozolomideE S Newlands, G Blackledge, J A Slack, et al.
Clinical Pharmacokinetics|July 8, 2000
Clinical pharmacokinetics of 2'-deoxy-2'-methylidenecytidine (DMDC), a deoxycytidine analogue antineoplastic agentC J Brindley, R Morrison, R J Gordon, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1994
Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administrationI Midgley, A J Hood, P Proctor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharideJ S de Bono, A G Dalgleish, J Carmichael, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Dose-proportional pharmacokinetics of cefepime in ratsC J Brindley, R R Brodie, S C Cook, et al.
Cancer Treatment Reports|July 1, 1985
Phase I clinical trial of mitozolomideE S Newlands, G Blackledge, J A Slack, et al.
Clinical Pharmacokinetics|July 8, 2000
Clinical pharmacokinetics of 2'-deoxy-2'-methylidenecytidine (DMDC), a deoxycytidine analogue antineoplastic agentC J Brindley, R Morrison, R J Gordon, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1994
Metabolic fate of 14C-camostat mesylate in man, rat and dog after intravenous administrationI Midgley, A J Hood, P Proctor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharideJ S de Bono, A G Dalgleish, J Carmichael, et al.
Pageof 2